KONE Oyj (OTCMKTS:KNYJY – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.04), Zacks reports. KONE Oyj had a return on equity of 39.77% and a net margin of 8.98%.
KONE Oyj Trading Down 0.9 %
Shares of OTCMKTS KNYJY traded down $0.24 during midday trading on Thursday, reaching $25.21. The company had a trading volume of 64,505 shares, compared to its average volume of 37,339. The stock has a market cap of $22.85 billion, a PE ratio of 24.48, a price-to-earnings-growth ratio of 3.32 and a beta of 0.69. KONE Oyj has a one year low of $22.69 and a one year high of $30.12. The company has a quick ratio of 0.89, a current ratio of 1.06 and a debt-to-equity ratio of 0.18. The firm’s fifty day moving average price is $24.88 and its 200-day moving average price is $26.20.
Analyst Ratings Changes
Separately, Royal Bank of Canada downgraded KONE Oyj from a “hold” rating to a “strong sell” rating in a research note on Monday, November 25th.
KONE Oyj Company Profile
KONE Oyj, together with its subsidiaries, engages in the elevator and escalator business worldwide. The company provides elevators, escalators, and automatic building doors. It offers maintenance services; and modernization solutions. In addition, the company offers KONE Office Flow, a connected solution that allows for personalized user experiences and touch-free access; health and well-being solutions for elevators, escalators, and doors; KONE Access, an access control system, which is integrated with elevator system and building doors; KONE Destination, a destination control system that reduce waiting and travel times; KONE infotainment, a communication channel for building tenants and visitors; and monitoring solutions that enable real-time inspection of elevators and escalators.
Read More
- Five stocks we like better than KONE Oyj
- Health Care Stocks Explained: Why You Might Want to Invest
- How Value Investors Find Undervalued Stocks and Build Wealth
- What Are Dividend Achievers? An Introduction
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- Trading Halts Explained
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
Receive News & Ratings for KONE Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KONE Oyj and related companies with MarketBeat.com's FREE daily email newsletter.